New

Cancer Vaccines Market

2021

Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer and Other Indications), End User (Pediatrics and Adults) and Geography

Publication Month: Sep 2020 | Report Code: TIPRE00004595 | No. of Pages: 179 | Category: Pharmaceuticals | Status: Published

Market Insights

Cancer Vaccines Market to Grow at a CAGR of 17.4% to reach US$ 15,845.59 Mn Million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The cancer vaccines market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; the market is estimated to grow at a CAGR of 17.2% from 2020 to 2027.
The cancer vaccines assist in the treatment of the existing cancer or prevent the development of cancer; the former are known as therapeutic cancer vaccines. Several vaccines are "autologous," as they are prepared from the samples obtained from cancer patients, and such vaccines are unique to that patient. Cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. Cervarix, Gardasil, Gardasil-9, and Hepatitis B (HBV) vaccine (HEPLISAV-B) are preventive cancer vaccines, whereas, Sipuleucel-T (Provenge) are therapeutic cancer vaccines. The global cancer vaccines market is driven by factors such as increasing R&D expenditures by pharmaceutical companies, and rising government support for research activities and clinical trials. However, the high cost of drug development hinders the market growth. However, emerging markets are creating growth opportunities for the market players.

Lucrative Regional Markets for Cancer Vaccines
Lucrative Regional Markets for Cancer Vaccines

Get more information on this report :



Market Insights

Increase in Prevalence of Cancer Worldwide

Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer would be a burden on society if not diagnosed and treated on time. According to the World Health Organization (WHO), in 2018, approximately 9.6 million deaths reported across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US. Approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in North America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancer remains the leading cancer in females. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and the disease lead to ~19,376 deaths in that year. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers have increased by 324% in India between 2017 and 2018.

Technology-Based Insights

On the basis of technology, the cancer vaccines market has been segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. The recombinant cancer vaccines segment held the largest share of the market in 2019, and it is further anticipated to register the highest CAGR in the market during the forecast period.

Cancer Vaccines Market, by Technology – 2018 and 2027
Cancer Vaccines Market, by Technology – 2018 and 2027

Get more information on this report :


Type-Based Insights

The cancer vaccines market, by type, is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR in the market during the forecast period.

Indication-Based Insights

The cancer vaccines market, by indication, is segmented into cervical cancer, prostate cancer, and other indications. The cervical cancer segment held the largest share of the market in 2019, and the market for this segment is anticipated to witness the highest CAGR during the forecast period.

End User-Based Insights

The cancer vaccines market, by end user, is segmented into pediatrics and adults. The pediatrics segment held a larger share of the market in 2019, and the same segment is anticipated to register a higher CAGR of 17.4% during the forecast period.

Strategic Insights

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios; these strategies help them meet the growing consumer demand. Collaboration is one of the major strategies adopted by the cancer vaccines market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

Global Cancer Vaccines Market – by Technology

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

Global Cancer Vaccines Market – by Type

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

Global Cancer Vaccines Market – by Indication

  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

Global Cancer Vaccines Market – by End User

  • Pediatrics
  • Adults

Cancer Vaccines Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • CSL Limited
  • ADURO BIOTECH INC.
  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Glaxosmithkline Plc.
  • Dendreon
  • ASTRAZENECA PLC.
  • OSE Immunotherapeutics

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Cancer Vaccines Market – By Technology

1.3.2 Global Cancer Vaccines Market – By Type

1.3.3 Global Cancer Vaccines Market – By Indication

1.3.4 Global Cancer Vaccines Market – By End-User

1.3.5 Global Cancer Vaccines market – By Geography

2. Cancer Vaccines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Cancer Vaccines Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa (MEA) – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Expert Opinions

5. Cancer Vaccines Market– Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increase in Prevalence of Cancer Worldwide

5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines

5.2 Key Market Restraints

5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer

5.2.2 Higher Cost of Cancer Vaccines

5.3 Key Market Opportunities

5.3.1 Emerging Markets in Developing Countries

5.4 Future Trends

5.4.1 Growing Research and Development Activities

5.5 Impact analysis

6. Cancer Vaccines Market – Global Analysis

6.1 Global Cancer Vaccines Market Revenue Forecast and Analysis

6.2 Global Cancer Vaccines Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. Cancer Vaccines Market – By Technology

7.1 Overview

7.2 Cancer Vaccines Market, by Technology, 2019 and 2027 (%)

7.3 Dendritic Cells Cancer Vaccine

7.3.1 Overview

7.3.2 Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Recombinant Cancer Vaccines

7.5.1 Overview

7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Antigen Cancer Vaccines

7.6.1 Overview

7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7 Whole Cell Cancer Vaccines

7.7.1 Overview

7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.8 Viral Vector Cancer Vaccines

7.8.1 Overview

7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8. Cancer Vaccines Market Analysis – By Type

8.1 Overview

8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)

8.3 Preventive Cancer Vaccines

8.3.1 Overview

8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Therapeutic Cancer Vaccines

8.4.1 Overview

8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9. Cancer Vaccines Market Analysis – By Indication

9.1 Overview

9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)

9.3 Cervical Cancer

9.3.1 Overview

9.3.2 Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Prostate Cancer

9.4.1 Overview

9.4.2 Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Other Indications

9.5.1 Overview

9.5.2 Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

10. Cancer Vaccines Market Analysis – By End Use

10.1 Overview

10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)

10.3 Pediatrics

10.3.1 Overview

10.3.2 Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

10.4 Adults

10.4.1 Overview

10.4.2 Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11. Cancer Vaccines Market Analysis And Forecasts To 2027 Geographical Analysis

11.1 North America: Cancer Vaccines Market

11.1.1 Overview

11.1.2 North America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.3 North America: Cancer Vaccines Market, by Technology, 2018–2027 (USD Million)

11.1.4 North America: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.5 North America: Cancer Vaccines Market, by Indication, 2018–2027 (USD Million)

11.1.6 North America: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

11.1.8 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 US: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.8.3 US: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.8.4 US: Cancer Vaccines Market, by Technology2018–2027 (USD Million)

11.1.8.5 US: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.9 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.1.10 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2 Europe: Cancer Vaccines Market

11.2.1 Overview

11.2.2 Europe: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)

11.2.3 Europe: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.4 Europe: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.5 Europe: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.6 Europe: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2.7 Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)

11.2.8 Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.1 Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.2 Germany: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.8.3 Germany: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.8.4 Germany: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.8.5 Germany: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2.9 UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.1 UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.2 UK: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.9.3 UK: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.9.4 UK: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.9.5 UK: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2.10 France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.1 France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.2 France: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.10.3 France: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.10.4 France: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.10.5 France: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2.11 Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.1 Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.2 Spain: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.11.3 Spain: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.11.4 Spain: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.11.5 Spain: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.2.12 Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.1 Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.2 Italy: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.2.12.3 Italy: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.2.12.4 Italy: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.2.12.5 Italy: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3 Asia Pacific: Cancer Vaccines Market

11.3.1 Overview

11.3.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)

11.3.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3.7 Asia Pacific: Cancer Vaccines Market, by Country, 2018 & 2027 (%)

11.3.8 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.1 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.2 China: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.8.3 China: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.8.4 China: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.8.5 China: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3.9 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.1 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.2 Japan: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.9.3 Japan: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.9.4 Japan: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.9.5 Japan: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3.10 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.1 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.2 India: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.10.3 India: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.10.4 India: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.10.5 India: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3.11 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.1 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.2 South Korea: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.11.3 South Korea: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.11.4 South Korea: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.11.5 South Korea: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.3.12 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.1 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.2 Australia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.3.12.3 Australia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.3.12.4 Australia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.3.12.5 Australia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.4 Middle East & Africa: Cancer Vaccines Market

11.4.1 Overview

11.4.2 Middle East & Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)

11.4.3 Middle East & Africa: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.4.4 Middle East & Africa: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.4.5 Middle East & Africa: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.4.6 Middle East & Africa: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.4.7 Middle East & Africa: Cancer Vaccines Market Share by Country – 2019 & 2027, (%)

11.4.8 Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.1 Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.4.8.2 Saudi Arabia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.4.8.3 Saudi Arabia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.4.8.4 Saudi Arabia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.4.8.5 Saudi Arabia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.4.9 UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.1 UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.4.9.2 UAE: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.4.9.3 UAE: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.4.9.4 UAE: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.4.9.5 UAE: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.4.10 South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.4.10.1 South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.4.10.2 South Africa: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)

11.4.10.3 South Africa: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)

11.4.10.4 South Africa: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)

11.4.10.5 South Africa: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)

11.5 South and Central America: Cancer Vaccines Market

11.5.1 Overview

11.5.2 South and Central America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.5.3 South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.5.4 South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

11.5.5 South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.5.6 South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.5.7 South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

11.5.8 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.1 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.5.8.2 Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.5.8.3 Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

11.5.8.4 Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.5.8.5 Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.5.9 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.1 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

11.5.9.2 Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

11.5.9.3 Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

11.5.9.4 Argentina Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.5.9.5 Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Rest of World: Impact Assessment of COVID-19 Pandemic

13. Cancer Vaccines Market – Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 CSL Limited

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 ADURO BIOTECH INC.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Astellas Pharma Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Bristol-Myers Squibb Company

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 GlaxoSmithKline plc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Dendreon

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 AstraZeneca

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Merck & Co., Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Sanofi (Sanofi Pasteur)

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 OSE Immunotherapeutics

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms


LIST OF TABLES

Table 1. North America Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 2. North America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3. North America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 4. North America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 5. Estimated Number of New Cancer Cases and Deaths, US, 2020

Table 6. US Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7. US Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 8. US Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 9. US Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 13. Canada Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Incidence, Mortality and Prevalence by cancer site in 2018

Table 15. Mexico Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 17. Mexico Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 18. Mexico Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19. Europe Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 20. Europe Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 21. Europe Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 22. Europe Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 23. Incidence, Mortality and Prevalence by cancer site, 2018, Germany

Table 24. Germany Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 25. Germany Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 26. Germany Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 27. Germany Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 28. UK Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29. UK Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 30. UK Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 31. UK Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 32. Incidence, Mortality and Prevalence by cancer site, 2018, France

Table 33. France Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 34. France Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 35. France Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 36. France Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 37. Incidence, Mortality and Prevalence by cancer site, 2018, Spain

Table 38. Spain Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39. Spain Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 40. Spain Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 41. Spain Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 42. Incidence, Mortality and Prevalence by cancer site, 2018, Italy

Table 43. Italy Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44. Italy Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 45. Italy Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 46. Italy Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 47. Asia Pacific Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 48. Asia Pacific Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 49. Asia Pacific Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 50. Asia Pacific Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 51. China Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 52. China Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 53. China Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 54. China Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 55. Japan Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 56. Japan Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 57. Japan Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 58. Japan Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 59. India Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 60. India Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 61. India Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 62. India Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 63. South Korea Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 64. South Korea Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 65. South Korea Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 66. South Korea Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 67. Incidence, Mortality and Prevalence by cancer site, Australia, 2018

Table 68. Australia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 69. Australia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 70. Australia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 71. Australia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 72. Middle East & Africa Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 73. Middle East & Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 74. Middle East & Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 75. Middle East & Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 76. Saudi Arabia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 77. Saudi Arabia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 78. Saudi Arabia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 79. Saudi Arabia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 80. UAE Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 81. UAE Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 82. UAE Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 83. UAE Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 84. South Africa Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 85. South Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 86. South Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)

Table 87. South Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 88. South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 89. South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 90. South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 91. South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 92. Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 93. Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 94. Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 95. Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 96. Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 97. Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)

Table 98. Argentina Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)

Table 99. Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 100. Organic Developments Done By Companies

Table 101. Inorganic Developments Done By Companies

Table 102. Glossary of Terms, Cancer Vaccines Market


LIST OF FIGURES

Figure 1. Cancer Vaccines Market Segmentation

Figure 2. Cancer Vaccines Market Segmentation, By Region

Figure 3. Cancer Vaccines Market Overview

Figure 4. Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market

Figure 5. APAC to Show Significant Growth During Forecast Period

Figure 6. Cancer Vaccines Market, by Geography (US$ Million)

Figure 7. Global Cancer Vaccines Market – Leading Country Markets (US$ Million)

Figure 8. Global Cancer Vaccines Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa (MEA) PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Cancer Statistics, 2020

Figure 15. Cancer Vaccines Market Impact Analysis of Driver and Restraints

Figure 16. Global Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027

Figure 17. Market Positioning Of Key Players In Global Cancer Vaccines Market

Figure 18. Cancer Vaccines Market, by Technology, 2019 and 2027 (%)

Figure 19. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)

Figure 25. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)

Figure 28. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)

Figure 32. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34. North America: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 35. North America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 36. North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

Figure 37. US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 38. Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 39. Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 40. Europe: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 41. Europe Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 42. Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)

Figure 43. Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 44. UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 45. France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 46. Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 47. Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 48. Asia Pacific: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 49. Asia Pacific Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 50. China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 51. Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 52. India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 53. South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 54. Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 55. Middle East & Africa: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 56. Middle East & Africa Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 57. Middle East & Africa: Cancer Vaccines Market Share by Country – 2019 & 2027, (%)

Figure 58. Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 59. UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 60. South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 61. South and Central America: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 62. South and Central America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 63. South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)

Figure 64. Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 65. Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 66. Impact of COVID-19 Pandemic in North American Country Markets

Figure 67. Impact of COVID-19 Pandemic in Europe Country Markets

Figure 68. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 69. Impact of COVID-19 Pandemic in Rest of World Country Markets

Figure 70. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Cancer Vaccines Market

  1. CSL Limited
  2. ADURO BIOTECH INC.
  3. Astellas Pharma Inc.
  4. Merck & Co. Inc.
  5. Sanofi
  6. Bristol-Myers Squibb Company
  7. Glaxosmithkline Plc.
  8. Dendreon
  9. ASTRAZENECA PLC.
  10. OSE Immunotherapeutics
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cancer vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00004595
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.